These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 18586274)

  • 1. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
    J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
    Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
    Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overweight and obesity affect treatment response in major depression.
    Kloiber S; Ising M; Reppermund S; Horstmann S; Dose T; Majer M; Zihl J; Pfister H; Unschuld PG; Holsboer F; Lucae S
    Biol Psychiatry; 2007 Aug; 62(4):321-6. PubMed ID: 17241618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression.
    O'Toole SM; Sekula LK; Rubin RT
    Biol Psychiatry; 1997 Jul; 42(2):85-9. PubMed ID: 9209724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
    Zobel AW; Schulze-Rauschenbach S; von Widdern OC; Metten M; Freymann N; Grasmäder K; Pfeiffer U; Schnell S; Wagner M; Maier W
    J Psychiatr Res; 2004; 38(4):377-83. PubMed ID: 15203289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M; Bschor T; Bauer M; Lucka C; Lewitzka U; Ising M; Uhr M; Mueller-Oerlinghausen B; Baethge C
    Neuropsychobiology; 2009; 60(1):23-30. PubMed ID: 19684420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
    J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression.
    Duval F; Mokrani MC; Erb A; Gonzalez Lopera F; Alexa C; Proudnikova X; Butucaru I
    Psychoneuroendocrinology; 2015 Sep; 59():71-80. PubMed ID: 26036452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test.
    Pintor L; Torres X; Navarro V; Martinez de Osaba MA; Matrai S; Gastó C
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):463-9. PubMed ID: 19302831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.